GSTM1, smoking and lung cancer: a case-control study

Int J Epidemiol. 1999 Oct;28(5):829-35. doi: 10.1093/ije/28.5.829.

Abstract

Background: We conducted a case-control study to examine the risk of lung cancer in relation to GSTM1 polymorphism and cigarette smoking (primarily of black tobacco) in a French population.

Methods: The 611 subjects were 301 incident lung cancer cases and 310 hospital controls. We were able to constitute a DNA bank for 547 subjects (89.5%) and gather detailed information on smoking history for all of them. Results presented here concern 247 cases and 254 controls.

Results: Taking non- or light smokers as the reference category, we estimated odds ratios (OR) of 4.2 (95% CI: 2.6-6.7) and 5.2 (95% CI: 3.3-8.3) for the medium and heavy smokers respectively. On the other hand we estimated that the crude OR associating GSTM1 with lung cancer was 1.3 (95% CI: 0.9-1.8). Furthermore our data do not depart significantly from a multiplicative model of the combined effects of smoking and GSTM1 deficiency.

Conclusions: We conclude that smoking and the GSTM1 gene are each a risk factor for lung cancer, and that their combined effect does not differ significantly from that of a multiplicative model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Distribution
  • Aged
  • Analysis of Variance
  • Case-Control Studies
  • Confidence Intervals
  • Female
  • France / epidemiology
  • Genetic Predisposition to Disease / epidemiology*
  • Glutathione Transferase / genetics*
  • Glutathione Transferase / metabolism
  • Health Surveys
  • Humans
  • Incidence
  • Lung Neoplasms / epidemiology*
  • Lung Neoplasms / genetics*
  • Male
  • Middle Aged
  • Odds Ratio
  • Polymorphism, Genetic*
  • Reference Values
  • Risk Assessment
  • Risk Factors
  • Sampling Studies
  • Smoking / adverse effects*
  • Smoking / epidemiology

Substances

  • Glutathione Transferase